[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2297 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 2297

To provide for a limitation on availability of funds for Related Agency 
and Food and Drug Administration, FDA Innovation Account, Cures Act for 
                           fiscal year 2024.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 29, 2023

Mr. Biggs (for himself, Mr. Rosendale, Mr. Gaetz, Mr. Good of Virginia, 
   Mr. Roy, and Mr. Crane) introduced the following bill; which was 
            referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
To provide for a limitation on availability of funds for Related Agency 
and Food and Drug Administration, FDA Innovation Account, Cures Act for 
                           fiscal year 2024.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LIMITATION ON AVAILABILITY OF FUNDS FOR RELATED AGENCY AND 
              FOOD AND DRUG ADMINISTRATION, FDA INNOVATION ACCOUNT, 
              CURES ACT FOR FISCAL YEAR 2024.

    Notwithstanding any other provision of the law, amounts authorized 
to be appropriated or otherwise available for Related Agency and Food 
and Drug Administration, FDA Innovation Account, Cures Act for fiscal 
year 2024 may not exceed $50,000,000.
                                 <all>